Risk Factors for the Development of Adverse Reactions in Patients with Newly Diagnosed Pulmonary Tuberculosis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Objective — to determine the risk factors for the development of adverse reactions in patients with newly diagnosed pulmonary tuberculosis. Materials and methods. A retrospective study was conducted based on the data of medical records (form TB 09) of 176 inpatients with newly diagnosed pulmonary tuberculosis, who were treated at the Kyiv Regional Specialised Medical Centre, Municipal Non-Commercial Enterprise of the Kyiv Regional Council. Results and discussion. It was established that most patients were male, financially vulnerable, had a history of long-term alcohol abuse, did not visit a general practitioner, did not undergo medical examination and were not aware of having any diseases. Every third patient, after the appearance of the first clinical symptoms that could indicate tuberculosis, did not seek medical care immediately but consulted a doctor at least one month later, which resulted in delayed diagnosis of pulmonary tuberculosis and its progression. Conclusions. Patients with newly diagnosed pulmonary tuberculosis in the presence of concomitant pathology have a high risk of liver damage because they receive anti-tuberculosis drugs. Hepatotoxicity caused by anti-tuberculosis drugs is a common occurrence and often leads to interruption or termination treatment. The results of our research revealed a relationship between the risk factors for the development of adverse reactions present before the beginning of treatment and tolerability of anti-tuberculosis drugs during the intensive phase of treatment. Understanding the importance of continuous use of anti-tuberculosis treatment and identifying appropriate methods of management of such patients are important for the effective completion of anti-tuberculosis treatment.
Fields of Study & Subjects
Tuberculosis Research and Epidemiology
Drug-Induced Hepatotoxicity and Protection
Infectious Diseases and Tuberculosis
Publication details
- Journal / source
- Tuberculosis Lung Diseases HIV Infection
- Issue
- 1
- Pages
- 22–26
- Publication date
- 26 March 2026
- Language
- EN